Kathy Burke

Kathy Burke has over 35 years of work experience, primarily in the pharmaceutical and medical device industry. Kathy has held various roles in market access, sales, and management.

Kathy'smost recent position is as the Vice President of Market Access at Osteal Therapeutics since 2022. Prior to this, they worked as the Executive Director and Head of Market Access at Spero Therapeutics from 2020. In this role, they led the pre-commercial market access strategy and built a market access leadership team.

From 2017 to 2020, Kathy Burke worked at Flexion Therapeutics, where they served as the Head of Market Access. Kathy was responsible for various market access functions and served as a strategic advisor for product development.

Before that, they worked at Regeneron Pharmaceuticals, Inc. from 2015 to 2017 as the Manager of Field Reimbursement and Access. Kathy established a reimbursement and access team and maintained payer coverage for several products.

From 2009 to 2015, Kathy Burke worked at Auxilium Pharmaceuticals, Inc. as a Regional Sales Director. Kathy built and managed a sales and reimbursement team for the launch of a biologic product.

Kathy also has experience at Luitpold, Medimmune, Kos Pharmaceuticals, RS Medical, and Zimmer Biomet, where they held various sales and management roles throughout their career.

Overall, Kathy Burke has a strong background in market access, sales, and team management in the pharmaceutical and medical device industry.

Kathy Burke holds a Bachelor's degree in Economics from the University of Florida. Kathy has also obtained a certification as a CPPM Certified Physician Practice Manager from the AAPC. No specific information is available regarding the years in which they obtained their certification or completed their degree.